--(BUSINESS WIRE)--Merck & Co., Inc. (NYSE: MRK)
TO: Journalists and Pharmaceutical Analysts
WHAT:
Merck & Co., Inc. will host a teleconference to provide an update on the U.S. VIOXX litigation
WHO: Richard T. Clark, chairman, president and chief executive officer
Peter N. Kellogg, executive vice president and chief financial officer
Kenneth C. Frazier, executive vice president and president, Global Human Health
Bruce N. Kuhlik, senior vice president and general counsel
Theodore V. H. Mayer, partner, Hughes Hubbard & Reed LLP
